Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS10020556
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10020556
Fusion event
HBV-SPATS2L integration
Validated
No
Detection method
VirusScan
Data source
Curated
Sample type
Tumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Good
Reported year
2016
PubMed ID
27339696
Virus Sequence
Virus name
HBV
Reference genome
NC_003977.1
Start
1268
End
2364
Orient
+
Integrated sequence
TACTGCGGAACTCCTAGCAGCTTGTTTTGCTCGCAGCCGGTCTGGAGCGAAACTTATCGGAACCGACAACTCAGTTGTCCTCTCTCGGAAATACACCTCCTTTCCATGGCTGCTAGGCTGTGCTGCCAACTGGATCCTGCGCGGGACGTCCTTTGTCTACGTCCCGTCGGCGCTGAATCCCGCGGACGACCCGTCTCGGGGCCGTTTGGGCCTCTACCGTCCCCTTCTTCATCTGCCGTTCCGGCCGACCACGGG
Host Sequence
Chromosome
chr2
Cytoband
q33.1
Reference genome
GRCh37/hg19
Start
201235150/200370427 (Hg38)
End
201236198/200371475 (Hg38)
Orient
+
Location type
Intronic
Fragile sites / regions
FRA2I
Target gene
SPATS2L
miRNAs that regulate target gene
hsa-mir-21-5p
;
hsa-mir-146a-5p
;
hsa-mir-103a-3p
;
hsa-mir-6833-3p
;
hsa-mir-4768-5p
;
hsa-mir-6873-3p
;
hsa-mir-433-3p
;
hsa-mir-7154-5p
;
hsa-mir-942-5p
;
hsa-mir-6845-3p
;
hsa-mir-4762-5p
;
hsa-mir-548av-3p
;
hsa-mir-548f-3p
;
hsa-mir-548e-3p
;
hsa-mir-548az-3p
;
hsa-mir-548ar-3p
;
hsa-mir-548a-3p
;
hsa-mir-548x-3p
;
hsa-mir-548j-3p
;
hsa-mir-548aq-3p
;
hsa-mir-548am-3p
;
hsa-mir-548aj-3p
;
hsa-mir-548ah-3p
;
hsa-mir-548ae-3p
;
hsa-mir-1273e
;
hsa-mir-25-3p
;
hsa-mir-25-5p
;
hsa-mir-32-5p
;
hsa-mir-363-3p
;
hsa-mir-367-3p
;
hsa-mir-377-5p
;
hsa-mir-4325
;
hsa-mir-4459
;
hsa-mir-4537
;
hsa-mir-455-3p
;
hsa-mir-4695-5p
;
hsa-mir-6086
;
hsa-mir-6087
;
hsa-mir-6499-3p
;
hsa-mir-6516-5p
;
hsa-mir-658
;
hsa-mir-665
;
hsa-mir-6840-3p
;
hsa-mir-7703
;
hsa-mir-92a-3p
;
hsa-mir-92b-3p
Nearest miRNA
hsa-mir-10b/Upstream/11237316; hsa-mir-1244-1/Downstream/6411759;
Nearest TSS
ENST00000437798/Upstream/19238;
ENST00000421573/Downstream/6530;
Nearest CpG islands
None/Target,
chr2-CpG: 135/Upstream/62658
,
chr2-CpG: 44/Downstream/154487
Upstream sequence
CAGGAACTTATGAAGCGGGCGGGTGACTGTGGTGACTTCACATGGGCCAAGAAACTCAGGGGTTCATTGCTGCAGGTGGGCTTTCAGGAAGGGGAGATTG
Downstream sequence
gatgcatggatccccattgtagaatatgtttgagcaaggtctggatggctatttaatgaggatattgACTGCGGGATTAACTTACAGCTCAGGAGTATGT
Target sequence
agtttcaatggattcacaactaggtttgcataacaaacccagagagtgccaaagaatgggtcagtgtaattgcggagggtaaccagtatagactctgttctattccagatctctctttatcagtgacatgaatgGTGATGATTTTGATGAAACAATAGAaataactgacatttattgaactcttatgtgtcaaaaactgttctattattctatatatattagtttatttaatcttcacaattctgtgtagttgat
Reference
Cao, S., et al.Divergent viral presentation among human tumors and adjacent normal tissues. Sci Rep,2016, 6: 28294.
Sample Information
×
Sample name
TCGA-G3-A3CH-11A-11R-A22L-07
Sample type
Tumor
Gender
Female
CpG Island Information
×
Download
Curate